Home > Search Results

Assessment of clinical effectiveness

Evidence for the clinical effectiveness of LAP + AI and TRA + AI for the first-line treatment of patients with HR+/HER2+ mBC was assessed by conducting a systematic review of published research evidence. The review was undertaken following the general principles published by the Centre for Reviews and Dissemination's (CRD's) guidance for undertaking reviews in health care.

Recent Activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...